Cargando…
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production
[Image: see text] The site-directed chemical conjugation of antibodies remains an area of great interest and active efforts within the antibody–drug conjugate (ADC) community. We previously reported a unique site modification using a class of immunoglobulin-G (IgG) Fc-affinity reagents to establish...
Autores principales: | Fujii, Tomohiro, Matsuda, Yutaka, Seki, Takuya, Shikida, Natsuki, Iwai, Yusuke, Ooba, Yuri, Takahashi, Kazutoshi, Isokawa, Muneki, Kawaguchi, Sayaka, Hatada, Noriko, Watanabe, Tomohiro, Takasugi, Rika, Nakayama, Akira, Shimbo, Kazutaka, Mendelsohn, Brian A., Okuzumi, Tatsuya, Yamada, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119932/ https://www.ncbi.nlm.nih.gov/pubmed/36894324 http://dx.doi.org/10.1021/acs.bioconjchem.3c00040 |
Ejemplares similares
-
A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation
por: Matsuda, Yutaka, et al.
Publicado: (2020) -
Good Manufacturing
Practice Strategy for Antibody–Drug
Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation
AJICAP
por: Matsuda, Yutaka, et al.
Publicado: (2019) -
Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics
por: Ito, Kenichiro, et al.
Publicado: (2022) -
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
por: Fujii, Tomohiro, et al.
Publicado: (2021) -
An Evolutionarily Conserved Coreceptor Gene Is Essential for CLAVATA Signaling in Marchantia polymorpha
por: Takahashi, Go, et al.
Publicado: (2021)